Company presentation

Clda bmo01

Phase 2b emerge study of cdx 011

Bmn 110 ph12 results

Docetaxel Versus Docetaxel/Cisplatin in NSCLC

GS Weekly Options Watch - May 11th

12702889

Lovenox trial scheduling

$SNGX Nnational.2.1.2010

Optr 03292011

Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease (Review)

Clda roth01

Goldman mnta

Astm restore cli update nov 2010

Clda griffin01

Novel therapies in hcc

Inhx buy nov 2010

5 understanding some basic trial designs in sarcomas (inclusive a placebo one) prof van der graaf nl

Asco 2012 abstract_45010_oral_final

Transforming time for prostate cancer therapies